EREG and head and neck squamous cell carcinoma: While it cannot be excluded that long-term EREG silencing may lead to the emergence of CTX resistance, the acute targeting of EREG combined with CTX is effective in reducing cell survival and could be a feasible antitumor strategy for HNSCC.